{"id":10995,"date":"2019-08-09T16:49:11","date_gmt":"2019-08-09T16:49:11","guid":{"rendered":"http:\/\/drupal.test\/projects\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/"},"modified":"2022-07-26T13:14:43","modified_gmt":"2022-07-26T17:14:43","slug":"epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour","status":"publish","type":"project","link":"https:\/\/dev.genomecanada.ca\/fr\/project\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/","title":{"rendered":"\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique"},"content":{"rendered":"<p>Le s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration bas\u00e9 sur l\u2019ADN fournit d\u2019importants renseignements sur les alt\u00e9rations de l\u2019ADN; toutefois, la plupart des m\u00e9dicaments oncologiques visent des cibles mol\u00e9culaires d\u00e9finies \u00e0 l\u2019\u00e9chelle des prot\u00e9ines. Il existe un besoin urgent pour de nouvelles \u00e9preuves diagnostiques qui \u00e9valuent l\u2019information cellulaire \u00e0 tous les niveaux (prot\u00e9ines, ARN et ADN) afin de faire des choix th\u00e9rapeutiques optimaux. Ce projet vise \u00e0 amalgamer les donn\u00e9es prot\u00e9omiques aux donn\u00e9es g\u00e9nomiques et transcriptomiques dans le but de mettre au point des \u00e9preuves diagnostiques compl\u00e9mentaires d\u00e9velopp\u00e9es en laboratoire pour les cancers de l\u2019enfant les plus courants. De plus, le partenariat entre NanoString Technologies et le D\u00e9partement de m\u00e9decine de laboratoire p\u00e9diatrique permettra de mettre \u00e0 profit leur expertise technologique, clinique et commerciale combin\u00e9e.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration bas\u00e9 sur l\u2019ADN fournit d\u2019importants renseignements sur les alt\u00e9rations de l\u2019ADN; toutefois, la plupart des m\u00e9dicaments oncologiques visent des cibles mol\u00e9culaires d\u00e9finies \u00e0 l\u2019\u00e9chelle des prot\u00e9ines. Il existe un besoin urgent pour de nouvelles \u00e9preuves diagnostiques qui \u00e9valuent l\u2019information cellulaire \u00e0 tous les niveaux (prot\u00e9ines, ARN et ADN) afin de [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[92],"genome-competitions":[210],"project-sector":[],"genome_centres":[108],"class_list":["post-10995","project","type-project","status-publish","hentry","project-categories-translation-fr","genome-competitions-programme-de-partenariats-pour-les-applications-de-la-genomique","genome_centres-ontario-genomics-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Le s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration bas\u00e9 sur l\u2019ADN fournit d\u2019importants renseignements sur les alt\u00e9rations de l\u2019ADN; toutefois, la plupart des m\u00e9dicaments oncologiques visent des cibles mol\u00e9culaires d\u00e9finies \u00e0 l\u2019\u00e9chelle des prot\u00e9ines. Il existe un besoin urgent pour de nouvelles \u00e9preuves diagnostiques qui \u00e9valuent l\u2019information cellulaire \u00e0 tous les niveaux (prot\u00e9ines, ARN et ADN) afin de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.genomecanada.ca\/fr\/project\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T17:14:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\\\/\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\\\/\",\"name\":\"\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2019-08-09T16:49:11+00:00\",\"dateModified\":\"2022-07-26T17:14:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/dev.genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique - GenomeCanada","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique - GenomeCanada","og_description":"Le s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration bas\u00e9 sur l\u2019ADN fournit d\u2019importants renseignements sur les alt\u00e9rations de l\u2019ADN; toutefois, la plupart des m\u00e9dicaments oncologiques visent des cibles mol\u00e9culaires d\u00e9finies \u00e0 l\u2019\u00e9chelle des prot\u00e9ines. Il existe un besoin urgent pour de nouvelles \u00e9preuves diagnostiques qui \u00e9valuent l\u2019information cellulaire \u00e0 tous les niveaux (prot\u00e9ines, ARN et ADN) afin de [&hellip;]","og_url":"https:\/\/dev.genomecanada.ca\/fr\/project\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T17:14:43+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/","url":"https:\/\/dev.genomecanada.ca\/fr\/project\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/","name":"\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique - GenomeCanada","isPartOf":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#website"},"datePublished":"2019-08-09T16:49:11+00:00","dateModified":"2022-07-26T17:14:43+00:00","breadcrumb":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.genomecanada.ca\/fr\/project\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/epreuves-diagnostiques-complementaires-basees-sur-la-plateforme-nanostring-ncounter-vantage-3d-pour\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"\u00c9preuves diagnostiques compl\u00e9mentaires bas\u00e9es sur la plateforme NanoString nCounter Vantage 3D pour la m\u00e9decine de pr\u00e9cision en canc\u00e9rologie p\u00e9diatrique"}]},{"@type":"WebSite","@id":"https:\/\/dev.genomecanada.ca\/fr\/#website","url":"https:\/\/dev.genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/dev.genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/dev.genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/dev.genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/dev.genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/dev.genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10995\/revisions"}],"wp:attachment":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=10995"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=10995"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=10995"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=10995"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=10995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}